XML 22 R12.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Cost-Method Investments | 9 Months Ended
--- | ---
Mar. 31, 2018
Cost-Method Investments [Abstract] |
Cost-Method Investments | (6) Cost-Method Investments ﻿ The aggregate carrying amount of our cost-method investments at March 31, 2018 and June 30, 2017, was $41.1 million and $38.3 million, respectively, and is included in the non-current balance of other assets on the condensed consolidated balance sheets. ﻿ We periodically evaluate the carrying value of our cost-method investments, when events and circumstances indicate that the carrying amount of an asset may not be recovered. We estimate the fair value of our cost-method investments to assess whether impairment losses shall be recorded using Level 3 inputs. These investments include our holdings in privately held service and research companies that are not exchange traded and therefore not supported with observable market prices. However, these investments are valued by reference to their net asset values that can be market supported and unobservable inputs including future cash flows. During the nine months ended March 31, 2018 and 2017, we recognized $3.6 million and $0.6 million, respectively, of impairment losses related to our cost-method investments. We have determined, after the impairment charge, that the fair value of our remaining investments exceed their carrying values. ﻿ The following table shows a reconciliation of the changes in our cost-method investments during the nine months ended March 31, 2018 and March 31, 2017 (in thousands):
﻿ |  |  |  |  |  |
﻿ |  | Nine Months Ended March 31,
﻿ |  | 2018 |  | 2017
﻿Balance at the beginning of the period |  | $ | 38,324 |  | $ | 33,815
﻿Investments |  |  | 6,445 |  |  | 6,464
﻿Impairment of cost-method investments |  |  | (3,620) |  |  | (588)
﻿Balance at the end of the period |  | $ | 41,149 |  | $ | 39,691

X
- Definition The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 325 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=75025870&loc=d3e40691-111596 + Details
Name: | us-gaap_CostMethodInvestmentsDescriptionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration